{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        718, 
        732
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2036, 
        2059
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        649, 
        676
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        478, 
        507
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        595, 
        621
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        709, 
        717
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        630, 
        637
      ]
    }
  ], 
  "Supplementary Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1366, 
        1398
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 11^9311^MOH|PIMS|CCO|20160505082409|A85A9D8A1D8B480AFF287A54FEE0F15AC36DC6DE|ORU^R01|99999999999999999999|P|2.5|||||\nPID|1||^^^^MRN^HOSPITAL 11&9999&MOH~9999999999&YD&ON^^^^JHN||XXXXX^XXXXXXXXXX^XXXX||99999999|M|||999 XXXXXXXXX^^^XX^X9X9X9^999|||||||||||||||||||N|\nOBR|1||BY00949204|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160421|||67164^XXXXXXX^XXXXXXX^^^XX.||||||||||||20160505|||F|||||||99999^XXXXXXX^XXXXXX^XXXXX^^XX|\n\n\n\n\n\n\n\nPath report.gross description\n\nSCO 2 fragments of tissue measuring from 0.1,0.3 cm in greatestnE\\dimension EIT.nE\\\n\n\nPath report.site of origin\n\nBiopsy sigmoid colonnE\\\n\n\nPath report.final diagnosis\n\nBIOPSIES OF SIGMOID COLON:nE\\- INVASIVE ADENOCARCINOMA.nE\\- IN VIEW OF THE RELATIVELY YOUNG AGE OF THE PATIENT, THEnE\\POSSIBILITY THAT THIS IS A LYNCH SYNDROME (HNPCC) CARCINOMAnE\\NEEDS TO BE CONSIDERED.nE\\- IS THERE A FAMILY HISTORY OF LARGE BOWEL CARCINOMA OR OTHERnE\\LYNCH SYNDROME-ASSOCIATED CARCINOMAS?nE\\- IMMUNOHISTOCHEMISTRY FOR MISMATCH REPAIR GENE PROTEINSnE\\(MSI) IS AN EXCELLENT SCREENING TEST FOR THIS WITH HIGHnE\\SENSITIVITY AND SPECIFICITY.nE\\- WE WILL CARRY OUT MISMATCH REPAIR GENE IMMUNOHISTOCHEMISTRYnE\\AND AN ADDITIONAL REPORT WILL BE ISSUED WHEN THESE STUDIES AREnE\\COMPLETED.nE\\- PLEASE ENSURE THAT THIS REPORT IS FORWARDED TO THE TREATINGnE\\SURGEON/THERAPIST.nE\\\n\n\nPath report.supplemental reports\n\nAdded on: 2016-05-03nE\\Previously resulted by:nE\\Pathologist: DR. X M.D., F.R.C.P.(C)nE\\(signature on file)nE\nE\\The tumour has been examined by immunohistochemistry for thenE\\mismatch repair gene products MLH1, MSH2, MSH6 and PMS2 withnE\\the following results:nE\nE\\MLH1: Normal (intact) nuclear staining.nE\\MSH2: Normal (intact) nuclear staining.nE\\MSH6: Normal (intact) nuclear staining.nE\\PMS2: Normal (intact) nuclear staining.nE\nE\\Intact nuclear staining with all four proteins is highlynE\\correlated(>99%) with microsatellite stability (MSS). PleasenE\\ensure that this report is forwarded to the treatingnE\\surgeon/therapist.nE\\\n\n\nPath report.relevant Hx\n\nMass, ca?nE\\\n\n\n"
}